A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections

Clinical trial NCT00994890 · TERMINATED

Trial details

NCT number: NCT00994890
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Osteoarthritis, Knee Osteoarthritis, Hip

Start date: 2009-11-17
Primary completion: 2010-12-07
Enrollment: 679

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.